Skip to content

Transdiagnostic therapy based on the research domain criteria framework for non-suicidal self-injury

Effectiveness of transdiagnostic therapy based on the research domain criteria framework compared with treatment as usual and transcranial direct current stimulation for youth non-suicidal self-injury: A randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20171029037068N1
Enrollment
68
Registered
2023-09-23
Start date
2022-06-02
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nonsuicidal self-injury.

Interventions

Intervention 1: Intervention group 1: TTB-RDoC is a group intervention program for youth with NSSI (18–30-year-olds). It comprises 16 sessions (twice a week) of 45 min. This program consists of four m

Sponsors

Ferdowsi University of Mashhad
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 30 Years

Inclusion criteria

Inclusion criteria: Primary DSM-5 diagnosis of non-suicidal self-injury (NSSI) No usage of medication Being at the age of 18-30 years old Speaking Persian fluently Ability to participate in all assessment and treatment sessions

Exclusion criteria

Exclusion criteria: Need for immediate medical treatment or the need for concurrent therapeutic interventions that would interfere with the treatment program Receiving a full course of pharmacotherapy or psychotherapy, within the past 5 years Having psychiatric disorders and substance abuse (except tobacco users) within twelve months before screening Current diagnosis of any mental disorder A history of epilepsy Significant head injury or other neurological conditions, or brain surgery A history of adverse reaction to tDCS or having a sensitive scalp Patient's opposition to collaboration at any time of research Having serious thoughts about suicide

Design outcomes

Primary

MeasureTime frame
Nonsuicidal self-injury. Timepoint: At baseline (pre-treatment), at 8th weeks (post-treatment), and after a 12-month post-treatment followup period. Method of measurement: Inventory of statements about self-injury (ISAS), Structured clinical interview for DSM-5 disorders-clinician version.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactImanollah Bigdeli

Ferdowsi University of Mashhad

ibigdeli@um.ac.ir+98 51 3880 5865

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026